DK0703786T3 - Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS - Google Patents
Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDSInfo
- Publication number
- DK0703786T3 DK0703786T3 DK94913518T DK94913518T DK0703786T3 DK 0703786 T3 DK0703786 T3 DK 0703786T3 DK 94913518 T DK94913518 T DK 94913518T DK 94913518 T DK94913518 T DK 94913518T DK 0703786 T3 DK0703786 T3 DK 0703786T3
- Authority
- DK
- Denmark
- Prior art keywords
- decapeptides
- nona
- aids
- treatment
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A61K38/105—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4320201A DE4320201A1 (de) | 1993-06-18 | 1993-06-18 | Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation |
PCT/EP1994/001037 WO1995000168A1 (de) | 1993-06-18 | 1994-04-02 | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0703786T3 true DK0703786T3 (da) | 2002-05-27 |
Family
ID=6490614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94913518T DK0703786T3 (da) | 1993-06-18 | 1994-04-02 | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS |
Country Status (24)
Country | Link |
---|---|
US (1) | US5985834A (da) |
EP (1) | EP0703786B1 (da) |
JP (1) | JPH08511784A (da) |
KR (1) | KR100352541B1 (da) |
CN (1) | CN1136915C (da) |
AT (1) | ATE213164T1 (da) |
AU (1) | AU688315B2 (da) |
BR (1) | BR9406893A (da) |
CZ (1) | CZ285997B6 (da) |
DE (2) | DE4320201A1 (da) |
DK (1) | DK0703786T3 (da) |
ES (1) | ES2172533T3 (da) |
FI (1) | FI113008B (da) |
HU (1) | HUT73673A (da) |
IL (1) | IL110045A (da) |
NO (1) | NO320945B1 (da) |
PL (1) | PL175580B1 (da) |
PT (1) | PT703786E (da) |
RU (1) | RU2154492C2 (da) |
SG (1) | SG52240A1 (da) |
TW (1) | TW370532B (da) |
UA (1) | UA41938C2 (da) |
WO (1) | WO1995000168A1 (da) |
ZA (1) | ZA944347B (da) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
US5932547A (en) | 1996-07-03 | 1999-08-03 | Alza Corporation | Non-aqueous polar aprotic peptide formulations |
US5916582A (en) * | 1996-07-03 | 1999-06-29 | Alza Corporation | Aqueous formulations of peptides |
US5981489A (en) * | 1996-07-18 | 1999-11-09 | Alza Corporation | Non-aqueous protic peptide formulations |
DE19728737C1 (de) * | 1997-07-04 | 1999-02-11 | Johannes Christian Groeninghen | Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten |
US8962558B2 (en) | 1997-07-04 | 2015-02-24 | Johannes C. van Groeninghen | Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3 |
MXPA02008870A (es) * | 2000-03-14 | 2003-06-24 | Zentaris Ag | Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos. |
DE10137174A1 (de) * | 2001-07-31 | 2003-02-13 | Zentaris Ag | Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität |
US20040138138A1 (en) * | 2001-08-02 | 2004-07-15 | Jurgen Engel | Use of LHRH-antagonists in doses that do not cause castration for the improvement of T-cell mediated immunity |
IL147138A0 (en) * | 2001-12-17 | 2002-08-14 | Yeda Res & Dev | Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation |
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
US7250514B1 (en) * | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CA2726247C (en) * | 2008-05-29 | 2018-06-26 | Isr Immune System Regulation Ab | Method and means for treating viral disease, in particular hiv/aids |
EP2682460B1 (en) | 2008-07-07 | 2017-04-26 | Oxford Nanopore Technologies Limited | Enzyme-pore constructs |
AU2009269792A1 (en) | 2008-07-07 | 2010-01-14 | Oxford Nanopore Technologies Limited | Base-detecting pore |
GB0820927D0 (en) | 2008-11-14 | 2008-12-24 | Isis Innovation | Method |
JP5843614B2 (ja) | 2009-01-30 | 2016-01-13 | オックスフォード ナノポア テクノロジーズ リミテッド | 膜貫通配列決定における核酸構築物のためのアダプター |
JP2012516145A (ja) * | 2009-01-30 | 2012-07-19 | オックスフォード ナノポア テクノロジーズ リミテッド | ハイブリダイゼーションリンカー |
GB0905140D0 (en) | 2009-03-25 | 2009-05-06 | Isis Innovation | Method |
BR112013020411B1 (pt) | 2011-02-11 | 2021-09-08 | Oxford Nanopore Technologies Limited | Monômero de msp mutante, construto, polinucleotídeo, poro, kit e aparelho para caracterizar uma sequência de ácido nucleico alvo, e, método para caracterizar uma sequência de ácido nucleico alvo |
JP6298404B2 (ja) | 2011-07-25 | 2018-03-20 | オックスフォード ナノポール テクノロジーズ リミテッド | 膜貫通ポアを用いる二重鎖ポリヌクレオチド配列決定のためのヘアピンループ方法 |
BR112014025157B1 (pt) | 2012-04-10 | 2022-02-08 | Oxford Nanopore Technologies Limited | Monômero de lisenina mutante, construto, poro, método para caracterizar um analito alvo, uso de um poro, e, kit |
US11155860B2 (en) | 2012-07-19 | 2021-10-26 | Oxford Nanopore Technologies Ltd. | SSB method |
BR112015021788B1 (pt) | 2013-03-08 | 2023-02-28 | Oxford Nanopore Technologies Plc | Métodos para mover uma ou mais helicases imobilizadas, para controlar o movimento de um polinucleotídeo alvo, para caracterizar um polinucleotídeo alvo e para controlar o carregamento de uma ou mais helicases em um polinucleotídeo alvo, uso de um poro de transmembrana e de um potencial aplicado e de um ou mais espaçadores, complexo, e, kit |
GB201314695D0 (en) | 2013-08-16 | 2013-10-02 | Oxford Nanopore Tech Ltd | Method |
GB201313477D0 (en) | 2013-07-29 | 2013-09-11 | Univ Leuven Kath | Nanopore biosensors for detection of proteins and nucleic acids |
GB201403096D0 (en) | 2014-02-21 | 2014-04-09 | Oxford Nanopore Tech Ltd | Sample preparation method |
US10167503B2 (en) | 2014-05-02 | 2019-01-01 | Oxford Nanopore Technologies Ltd. | Mutant pores |
CN117164684A (zh) | 2014-09-01 | 2023-12-05 | 弗拉芒区生物技术研究所 | 突变csgg孔 |
EP3204511B1 (en) | 2014-10-07 | 2021-07-28 | Oxford Nanopore Technologies Limited | Mutant pores |
GB201418159D0 (en) | 2014-10-14 | 2014-11-26 | Oxford Nanopore Tech Ltd | Method |
CN105837674A (zh) * | 2016-03-08 | 2016-08-10 | 无限极(中国)有限公司 | 一种东方铃蟾多肽及其制备方法与应用 |
GB201609220D0 (en) | 2016-05-25 | 2016-07-06 | Oxford Nanopore Tech Ltd | Method |
GB201807793D0 (en) | 2018-05-14 | 2018-06-27 | Oxford Nanopore Tech Ltd | Method |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4677193A (en) * | 1985-02-22 | 1987-06-30 | The Salk Institute For Biological Studies | Peptides containing an aliphatic-aromatic ketone side chain |
US5073624A (en) * | 1985-04-09 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Therapeutic decapeptides |
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
WO1989009229A1 (en) * | 1988-03-31 | 1989-10-05 | Immunobiology Research Institute, Inc. | Treatment of hiv viremic patients with thymopentin |
HU208439B (en) * | 1988-10-14 | 1993-10-28 | Univ Tulane | Process for producing pharmaceutical peptides |
US5244883A (en) * | 1990-11-29 | 1993-09-14 | The Administrators Of The Tulane Educational Fund | Nonapeptide bombesin antagonists |
CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
-
1993
- 1993-06-18 DE DE4320201A patent/DE4320201A1/de not_active Ceased
-
1994
- 1994-04-02 EP EP94913518A patent/EP0703786B1/de not_active Expired - Lifetime
- 1994-04-02 AU AU65647/94A patent/AU688315B2/en not_active Ceased
- 1994-04-02 AT AT94913518T patent/ATE213164T1/de not_active IP Right Cessation
- 1994-04-02 JP JP7502363A patent/JPH08511784A/ja active Pending
- 1994-04-02 UA UA96010026A patent/UA41938C2/uk unknown
- 1994-04-02 SG SG1996001140A patent/SG52240A1/en unknown
- 1994-04-02 PT PT94913518T patent/PT703786E/pt unknown
- 1994-04-02 DK DK94913518T patent/DK0703786T3/da active
- 1994-04-02 RU RU96101145/14A patent/RU2154492C2/ru not_active IP Right Cessation
- 1994-04-02 PL PL94312219A patent/PL175580B1/pl not_active IP Right Cessation
- 1994-04-02 BR BR9406893A patent/BR9406893A/pt not_active Application Discontinuation
- 1994-04-02 DE DE59410052T patent/DE59410052D1/de not_active Expired - Fee Related
- 1994-04-02 ES ES94913518T patent/ES2172533T3/es not_active Expired - Lifetime
- 1994-04-02 CZ CZ953089A patent/CZ285997B6/cs not_active IP Right Cessation
- 1994-04-02 WO PCT/EP1994/001037 patent/WO1995000168A1/de active IP Right Grant
- 1994-04-02 US US08/569,111 patent/US5985834A/en not_active Expired - Fee Related
- 1994-04-02 KR KR1019950705735A patent/KR100352541B1/ko not_active IP Right Cessation
- 1994-04-02 CN CNB94192470XA patent/CN1136915C/zh not_active Expired - Fee Related
- 1994-04-02 HU HU9503605A patent/HUT73673A/hu unknown
- 1994-04-16 TW TW083103400A patent/TW370532B/zh active
- 1994-06-17 ZA ZA944347A patent/ZA944347B/xx unknown
- 1994-06-17 IL IL11004594A patent/IL110045A/xx not_active IP Right Cessation
-
1995
- 1995-12-08 NO NO19954996A patent/NO320945B1/no unknown
- 1995-12-14 FI FI956014A patent/FI113008B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
MXPA05008406A (es) | Compuestos de amida tri(ciclo)-sustituida. | |
DK1036058T3 (da) | Adamantanderivater | |
DK1036059T3 (da) | Adamantanderivater | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
MY125978A (en) | Admantane derivatives | |
DK0839026T3 (da) | Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof | |
NZ525774A (en) | Use of SARP-1 for the treatment and/or prevention of scleroderma | |
AU2811400A (en) | Stable formulation containing fumagillin | |
WO1998050397A3 (de) | Chimäre oligonucleotide und ihre verwendung | |
AU5870298A (en) | 1,4-dihydropyridin derivatives and their use in therapy | |
HK1058305A1 (en) | Combinations of dalfopristine/quinupristine with cefpirome | |
WO2000067733A3 (de) | Medikament zur therapie der männlichen infertilität | |
UA32315A (uk) | Спосіб накладання шкірного шва | |
UA32580C2 (uk) | Засіб для лікування паралітичної непрохідності кишечнику | |
UA35854A (uk) | Спосіб лікування приховано протікаючого силікотуберкульозу | |
UA32280A (uk) | Спосіб формування тонко-товстокишкового анастомозу бік у бік | |
CA2162468A1 (en) | Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |